Search Results - "Lubinga, S.J." :: K.UTB vyhledávací portál

Loading…

A Cost-effectiveness analysis of Antipsychotics for treatment of Schizophrenia in Uganda

by Lubinga, S.J, Mutamba, B.B, Nganizi, A, Babigumira, J.B
Published in Value in health (01.05.2015)

Get full text

Journal Article

Loading…

Potential Cost-Effectiveness Of Prenatal Distribution Of Misoprostol For Prevention Of Post Partum Hemorrhage In Uganda

by Lubinga, S.J, Atukunda, E, Ssalongo, G.W, Babigumira, J.B
Published in Value in health (01.05.2014)

Get full text

Journal Article

Loading…

Impact Of Abortion Complications On Health-Related Quality Of Life In Uganda

by Lubinga, S.J, Levine, G.A, Jenny, A, Stergachis, A, Babigumira, J.B
Published in Value in health (01.05.2013)

Get full text

Journal Article

Loading…

1135P Adverse event (AE) burden of nivolumab-based immuno-oncology (IO) therapy with/without chemotherapy (chemo) for first-line (1L) advanced non-small cell lung cancer (aNSCLC)

by Schwartzberg, L., Wu, A., Hartman, J., Wang, T., Yin, X., Chen, J., Betts, K.A., Lubinga, S.J.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

Loading…

734P Impact of investigator-assessed response on overall survival (OS) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

by Mathews, C., Koliadi, A., Gilbert, L., Slomovitz, B.M., Frühauf, F., Buttin, B., Özgül, N., Monk, B.J., Fountzilas, G., Billingsley, C., Trinidad, J., Braly, P., Boone, J., Black, D., Sharma, S., Lubinga, S.J., Sharpe, D.J., Ronzino, G., Powell, M.A., Mirza, M.R.
Published in Annals of oncology (01.09.2024)

Get full text

Journal Article

Loading…

1498P - Real-world effectiveness of nivolumab monotherapy after prior systemic therapy in advanced non-small cell lung cancer (NSCLC) in the United States

by Stenehjem, D.D., Lubinga, S.J., Gupte-Singh, K., Zhang, Y., Trong, K Le, Penrod, J.R.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

Real-world effectiveness of nivolumab monotherapy after prior systemic therapy in advanced non-small cell lung cancer (NSCLC) in the United States

by Stenehjem, D.D., Lubinga, S.J., Gupte-Singh, K., Zhang, Y., Trong, K Le, Penrod, J.R.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

1282P Trial-based costs of all-cause adverse events in first-line therapy for advanced non-small cell lung cancer: Findings from CheckMate-227

by Lubinga, S.J., King, S.B., Betts, K.A., Rao, S., Castriota, F., Mahin, M., Orvis, E., Marathe, S., Ma, J., Stenehjem, D.
Published in Annals of oncology (01.09.2020)

Get full text

Journal Article

Loading…

1316P Trial-based costs of all-cause adverse events in first-line therapy for advanced non-small cell lung cancer: Findings from CheckMate-9LA

by Stenehjem, D., Lubinga, S.J., King, S.B., Betts, K.A., Rao, S., Castriota, F., Mahin, M., Orvis, E., Marathe, S., Ma, J.
Published in Annals of oncology (01.09.2020)

Get full text

Journal Article

Loading…

MO01.02 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the United States

by Berling, M., Chaudhary, M.A., Yuan, Y., Varol, N., Dale, P., Testa, E., Klint, J., Lee, A., Lubinga, S.J., Penrod, J.R.
Published in Journal of thoracic oncology (01.01.2021)

Get full text

Journal Article

Loading…

PRO24 COST-EFFECTIVENESS OF LANADELUMAB AND C1-INHIBITORS FOR PROPHYLAXIS AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA

by Lubinga, S.J., Agboola, F.O., Lin, G., Seidner, M., Rind, D., Carlson, J.
Published in Value in health (01.05.2019)

Get full text

Journal Article

Loading…

EC1 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in the United States

by Polyzoi, M., Sandhu, H., Maervoet, J., Yuan, Y., Chaudhary, M., Varol, N., Lee, A., Dale, P., Jones, C., Lubinga, S.J., Penrod, J.R.
Published in Value in health (01.06.2021)

Get full text

Journal Article